138 related articles for article (PubMed ID: 3496073)
41. Dialysis leukopenia, hypoxemia, and anaphylatoxin formation: effect of membrane, bath, and citrate anticoagulation.
Wiegmann TB; MacDougall ML; Diederich DA
Am J Kidney Dis; 1988 May; 11(5):418-24. PubMed ID: 3259402
[TBL] [Abstract][Full Text] [Related]
42. Radiocontrast reactions.
Lieberman P; Siegle RL; Treadwell G
Clin Rev Allergy; 1986 May; 4(2):229-45. PubMed ID: 2870792
[No Abstract] [Full Text] [Related]
43. Antibody responses to hemodialysis-related antigens in chronic hemodialysis patients.
Dolovich J; Evans S; Baurmeister U; Schulze H; Ali M; Shimizu A
Artif Organs; 1987 Apr; 11(2):93-6. PubMed ID: 3593051
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of complement component C5 prevents clotting in an ex vivo model of xenogeneic activation of coagulation.
Rataj D; Werwitzke S; Haarmeijer B; Winkler M; Ramackers W; Petersen B; Niemann H; Wünsch A; Bähr A; Klymiuk N; Wolf E; Abicht JM; Ayares D; Tiede A
Xenotransplantation; 2016 Mar; 23(2):117-27. PubMed ID: 26773447
[TBL] [Abstract][Full Text] [Related]
45. Mechanisms of acute allergic reactions.
Hamilton RG; Adkinson NF
Artif Organs; 1984 Aug; 8(3):311-7. PubMed ID: 6477199
[TBL] [Abstract][Full Text] [Related]
46. First-use syndrome and hypersensitivity during hemodialysis: some pieces of the puzzle are falling into place.
Ing TS; Ivanovich PT; Daugirdas JT
Artif Organs; 1987 Apr; 11(2):79-81. PubMed ID: 3593048
[No Abstract] [Full Text] [Related]
47. Effect of permeability on indices of haemodialysis membrane biocompatibility.
Masaki T; Gilson J; Leypoldt JK; Cheung AK
Nephrol Dial Transplant; 1999 May; 14(5):1176-81. PubMed ID: 10344358
[TBL] [Abstract][Full Text] [Related]
48. Relative importance of membrane Limulus amebocyte lysate-reactive material and ethylene oxide in hypersensitivity reactions.
Pearson FC
Contrib Nephrol; 1987; 59():134-44. PubMed ID: 3442983
[No Abstract] [Full Text] [Related]
49. Clinical sequelae of complement activation in hemodialysis.
Hakim RM
Clin Nephrol; 1986; 26 Suppl 1():S9-12. PubMed ID: 3829474
[TBL] [Abstract][Full Text] [Related]
50. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
Schifferli JA; Steiger G; Paccaud JP
Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
[TBL] [Abstract][Full Text] [Related]
51. Role of dialyzer contaminants in the allergic epiphenomena of hemodialysis.
Ward RA; Feldhoff PW; Klein E
Artif Organs; 1984 Aug; 8(3):338-49. PubMed ID: 6477203
[TBL] [Abstract][Full Text] [Related]
52. [Acute adverse effects of dialysis].
Opatrný K
Vnitr Lek; 2003 Feb; 49(2):134-42. PubMed ID: 12733493
[TBL] [Abstract][Full Text] [Related]
53. Plasmin activity and complement activation during storage of citrated platelet concentrates.
Bode AP; Miller DT; Newman SL; Castellani WJ; Norris HT
J Lab Clin Med; 1989 Jan; 113(1):94-102. PubMed ID: 2521240
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of complement activation with EDTA in vivo during sham hemodialysis.
Kandus A; Benedik M; Bren AF; Drinovec J; Fliser D; Knap B; Kladnik S; Ivanovich P
Int J Artif Organs; 1991 Aug; 14(8):515-7. PubMed ID: 1937941
[TBL] [Abstract][Full Text] [Related]
55. Cardiac anaphylaxis. Complement activation as an amplification system.
del Balzo U; Polley MJ; Levi R
Circ Res; 1989 Sep; 65(3):847-57. PubMed ID: 2475275
[TBL] [Abstract][Full Text] [Related]
56. Severe hypersensitivity reaction during hemodialysis.
Kraske GK; Shinaberger JH; Klaustermeyer WB
Ann Allergy Asthma Immunol; 1997 Feb; 78(2):217-20. PubMed ID: 9048531
[TBL] [Abstract][Full Text] [Related]
57. Association of ethylene-oxide-induced IgE antibodies with symptoms in dialysis patients.
Rumpf KW; Seubert S; Seubert A; Lowitz HD; Valentin R; Rippe H; Ippen H; Scheler F
Lancet; 1985 Dec 21-28; 2(8469-70):1385-7. PubMed ID: 2867392
[TBL] [Abstract][Full Text] [Related]
58. In vitro inhibition of the classical and alternate pathways of activation of human complement by N acetyl aspartyl glutamic acid (NAAGA).
Etievant M; Leluc B; David B
Agents Actions; 1988 Jun; 24(1-2):137-44. PubMed ID: 3261498
[TBL] [Abstract][Full Text] [Related]
59. Modified cellulosic dialyzer membranes: an investigative tool in thrombogenicity studies.
Mahiout A; Meinhold H; Kessel M; Vienken J; Baurmeister U
ASAIO Trans; 1988; 34(3):878-81. PubMed ID: 3058187
[TBL] [Abstract][Full Text] [Related]
60. Ethylene-oxide and steam-sterilised polysulfone membrane in dialysis patients with eosinophilia.
Santoro A; Ferrari G; Francioso A; Zucchelli P; Duranti E; Sasdelli M; Rosati A; Salvadori M; Sanna GM; Briganti M; Fusaroli M; Lindner G; Stefani A; Borgatti P; Badiali F; Mignani R; Cagnoli L; Aucella F; Stallone C; Massazza M; Borghi M; Gualandris L; Modoni S; Grandone E; Orlandini G
Int J Artif Organs; 1996 Jun; 19(6):329-35. PubMed ID: 8814494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
